• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝基呋喃类药物在尿路感染治疗中作用的最新进展。

An update on the role of nitrofurans in the management of urinary tract infections.

作者信息

Guay D R

机构信息

University of Minnesota, Institute for the Study of Geriatric Pharmacotherapy, and College of Pharmacy and Partnering Care Senior Services, HealthPartners, Minneapolis 55455, USA.

出版信息

Drugs. 2001;61(3):353-64. doi: 10.2165/00003495-200161030-00004.

DOI:10.2165/00003495-200161030-00004
PMID:11293646
Abstract

There have been few recent reviews of the nitrofurans in the literature, and none include recently available data on the use of nitrofurazone (nitrofural) in the prevention of catheter-associated urinary tract infection (CAUTI). Nitrofurazone and nitrofurantoin are the only nitrofurans that have become established in clinical use in the 20th century. These 2 nitrofurans have remained clinically useful against a wide spectrum of gram-positive and gram-negative bacteria, including many strains of common urinary tract pathogens. Today, the primary use of nitrofurantoin is as an oral antibacterial treatment for genitourinary infections. Nitrofurazone is primarily used as a topical antibacterial agent in burns and skin grafts and recently was approved for the prophylaxis of CAUTI. The recent development of a nitrofurazone-impregnated catheter as a novel modality in the prevention of CAUTI reflects a renewed interest in the effectiveness of nitrofurans. In an era when concern about bacterial resistance to many anti-infective agents is growing, the nitrofurans have continued to be active against organisms that have developed resistance to antibacterials. The presence of multiple mechanisms of action for the nitrofurans might be expected to reduce the ability of bacteria to develop resistance. Considering that an emergence of resistance to the nitrofurans has not appreciably occurred after several decades of clinical use, the nitrofurans may be unique among common antibacterial agents in this regard.

摘要

近期文献中对硝基呋喃类药物的综述较少,且均未纳入有关呋喃西林(硝基糠醛)预防导管相关尿路感染(CAUTI)的最新可用数据。呋喃西林和呋喃妥因是20世纪已确立临床应用的仅有的两种硝基呋喃类药物。这两种硝基呋喃类药物对多种革兰氏阳性菌和革兰氏阴性菌仍具有临床疗效,包括许多常见的尿路病原体菌株。如今,呋喃妥因的主要用途是作为泌尿生殖系统感染的口服抗菌治疗药物。呋喃西林主要用作烧伤和皮肤移植的局部抗菌剂,最近被批准用于预防CAUTI。一种含呋喃西林的导管作为预防CAUTI的新方法的最新研发,反映出人们对硝基呋喃类药物有效性的重新关注。在一个对许多抗感染药物的细菌耐药性担忧日益增加的时代,硝基呋喃类药物对已对抗菌药物产生耐药性的微生物仍具有活性。硝基呋喃类药物存在多种作用机制,可能会降低细菌产生耐药性的能力。鉴于经过数十年临床应用后,硝基呋喃类药物并未明显出现耐药性,在这方面,硝基呋喃类药物在常见抗菌药物中可能是独一无二的。

相似文献

1
An update on the role of nitrofurans in the management of urinary tract infections.硝基呋喃类药物在尿路感染治疗中作用的最新进展。
Drugs. 2001;61(3):353-64. doi: 10.2165/00003495-200161030-00004.
2
[Nitrofurans: a modern treatment for uncomplicated urinary infections?].[硝基呋喃类药物:治疗单纯性泌尿系统感染的现代疗法?]
Pathol Biol (Paris). 2000 Jun;48(5):470-1.
3
Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens.呋喃西林基质导尿管对导管相关尿路病原体的活性。
Antimicrob Agents Chemother. 1993 Sep;37(9):2033-6. doi: 10.1128/AAC.37.9.2033.
4
Development of antibacterial resistance: the Dutch experience.抗菌耐药性的发展:荷兰的经验
J Antimicrob Chemother. 1994 May;33 Suppl A:17-22. doi: 10.1093/jac/33.suppl_a.17.
5
Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?从 PK/PD 角度优化呋喃妥因的剂量:我们需要了解什么?
Drug Resist Updat. 2019 Mar;43:1-9. doi: 10.1016/j.drup.2019.03.001. Epub 2019 Mar 20.
6
Antibiotic Prophylaxis During Catheter-Managed Postoperative Urinary Retention After Pelvic Reconstructive Surgery: A Randomized Controlled Trial.经尿道留置导尿在骨盆重建术后尿潴留的应用:一项随机对照试验。
Obstet Gynecol. 2019 Oct;134(4):727-735. doi: 10.1097/AOG.0000000000003462.
7
Comparative in vitro activity of five nitrofurans.五种硝基呋喃的体外活性比较
Chemotherapy. 1978;24(3):161-5. doi: 10.1159/000237776.
8
[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].[单纯性尿路感染,2006年的磷霉素和呋喃妥因情况如何?]
Pathol Biol (Paris). 2006 Oct-Nov;54(8-9):462-6. doi: 10.1016/j.patbio.2006.07.016. Epub 2006 Oct 5.
9
Nitrofurantoin: an effective and ignored antimicrobial.呋喃妥因:一种有效却被忽视的抗菌药物。
Int J Antimicrob Agents. 2006 Apr;27(4):354-5. doi: 10.1016/j.ijantimicag.2006.02.001. Epub 2006 Mar 13.
10
[Susceptibility of E. coli strains to nitrofurans with special reference to acquiring resistance in vitro].[大肠杆菌菌株对硝基呋喃类药物的敏感性,特别提及体外获得耐药性的情况]
Pol Arch Weter. 1972;15(4):679-88.

引用本文的文献

1
''Myth Busting in Infectious Diseases'': A Comprehensive Review.《传染病中的谣言破除》:全面综述
Cureus. 2024 Mar 30;16(3):e57238. doi: 10.7759/cureus.57238. eCollection 2024 Mar.
2
History Is the Key to Diagnosis: A Case of Nitrofurantoin-Induced Interstitial Lung Disease.病史是诊断的关键:一例呋喃妥因诱发的间质性肺病病例
Cureus. 2024 Mar 13;16(3):e56097. doi: 10.7759/cureus.56097. eCollection 2024 Mar.
3
Synthesis and Characterization of New N-acyl Hydrazone Derivatives of Carprofen as Potential Tuberculostatic Agents.

本文引用的文献

1
Studies on bacterial resistance to furacin.
Antibiot Chemother (Northfield). 1952 Mar;2(3):123-9.
2
Clinical observations on furacin soluble dressing in the treatment of surface infections.呋哺西林可溶性敷料治疗体表感染的临床观察
Surg Gynecol Obstet. 1947 Mar;84(3):366-72.
3
RE-EVALUATION OF FURACIN AS A LOCAL AGENT IN THE TREATMENT OF SURFACE INFECTIONS.对呋西那(呋喃西林)作为局部用药治疗体表感染的再评估
Am Surg. 1965 Apr;31:238-41.
卡洛芬新型N-酰腙衍生物作为潜在抗结核药物的合成与表征
Antibiotics (Basel). 2024 Feb 23;13(3):212. doi: 10.3390/antibiotics13030212.
4
-Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years.酰腙药效团的镇痛和抗炎特性:过去十年的最新进展。
Curr Pharm Des. 2024;30(5):333-351. doi: 10.2174/0113816128282470240117072322.
5
In Vitro Activities of Oxazolidinone Antibiotics Alone and in Combination with C-TEMPO against Methicillin-Resistant Biofilms.恶唑烷酮类抗生素单独及与C-TEMPO联合对耐甲氧西林生物被膜的体外活性
Antibiotics (Basel). 2023 Dec 7;12(12):1706. doi: 10.3390/antibiotics12121706.
6
Design and Synthesis of Novel Antimicrobial Agents.新型抗菌剂的设计与合成
Antibiotics (Basel). 2023 Mar 22;12(3):628. doi: 10.3390/antibiotics12030628.
7
Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors.2-巯基苯并恶唑衍生物作为潜在多激酶抑制剂的设计、合成及生物学评价
Pharmaceuticals (Basel). 2023 Jan 9;16(1):97. doi: 10.3390/ph16010097.
8
Genomic Analysis of Two MDR Isolates of Serovar Infantis from a Spanish Hospital Bearing the Gene with or without in pESI-like Plasmids.对西班牙一家医院分离出的两株多重耐药婴儿沙门氏菌血清型菌株进行基因组分析,这些菌株携带位于类pESI质粒上有或无[具体基因]的[另一基因]。
Antibiotics (Basel). 2022 Jun 9;11(6):786. doi: 10.3390/antibiotics11060786.
9
Analysis of multiple bacterial species and antibiotic classes reveals large variation in the association between seasonal antibiotic use and resistance.分析多种细菌种类和抗生素类别表明,季节性使用抗生素与耐药性之间的关联存在很大差异。
PLoS Biol. 2022 Mar 9;20(3):e3001579. doi: 10.1371/journal.pbio.3001579. eCollection 2022 Mar.
10
A Combined Experimental and Theoretical Study of Nitrofuran Antibiotics: Crystal Structures, DFT Computations, Sublimation and Solution Thermodynamics.硝基呋喃类抗生素的实验与理论综合研究:晶体结构、DFT 计算、升华和溶液热力学。
Molecules. 2021 Jun 5;26(11):3444. doi: 10.3390/molecules26113444.
4
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).女性单纯性急性细菌性膀胱炎和急性肾盂肾炎抗菌治疗指南。美国传染病学会(IDSA)。
Clin Infect Dis. 1999 Oct;29(4):745-58. doi: 10.1086/520427.
5
Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection.含呋喃西林导尿管和银水凝胶导尿管对导尿管相关尿路感染特征性多重耐药菌的抗菌活性。
Antimicrob Agents Chemother. 1999 Dec;43(12):2990-5. doi: 10.1128/AAC.43.12.2990.
6
A prospective study of pathogenesis of catheter-associated urinary tract infections.导管相关尿路感染发病机制的前瞻性研究。
Mayo Clin Proc. 1999 Feb;74(2):131-6. doi: 10.4065/74.2.131.
7
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.导致女性急性单纯性膀胱炎的尿路病原体中抗菌药物耐药性的患病率不断上升。
JAMA. 1999 Feb 24;281(8):736-8. doi: 10.1001/jama.281.8.736.
8
Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience.长期使用呋喃妥因治疗泌尿系统感染的疗效和安全性:18年经验
J Antimicrob Chemother. 1998 Sep;42(3):363-71. doi: 10.1093/jac/42.3.363.
9
Catheter-associated urinary tract infections.导尿管相关尿路感染
Infect Dis Clin North Am. 1997 Sep;11(3):609-22. doi: 10.1016/s0891-5520(05)70376-7.
10
Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens.呋喃西林基质导尿管对导管相关尿路病原体的活性。
Antimicrob Agents Chemother. 1993 Sep;37(9):2033-6. doi: 10.1128/AAC.37.9.2033.